ScholarGate
Assistent

Methoden vergleichen

Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.

Abgeglichene Phase-IV-Studie×Kohortenstudie×
FachgebietEpidemiologieEpidemiologie
FamilieProcess / pipelineProcess / pipeline
Entstehungsjahr1980s–1990s (formalized in post-marketing regulatory frameworks)Mid-20th century (formal epidemiological design codified ~1950s)
UrheberRegulatory tradition (FDA, EMA); matching methodology from Rosenbaum & Rubin (1983)Doll & Hill (British Doctors Study, 1951); Snow (cholera, 1854)
TypObservational study designObservational longitudinal study design
Wegweisende QuelleStrom, B. L., & Kimmel, S. E. (Eds.). (2005). Textbook of Pharmacoepidemiology. Wiley. ISBN: 978-0470029244Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641
Aliasnamenmatched post-marketing surveillance study, Phase IV matched cohort study, matched pharmacoepidemiological study, post-authorization matched safety studylongitudinal study, follow-up study, panel study, incidence study
Verwandt56
ZusammenfassungA Matched Phase IV study is a post-marketing observational design in which patients who received an approved drug (or intervention) are matched to comparable non-exposed patients — or patients on an alternative therapy — to evaluate real-world safety, effectiveness, or long-term outcomes. Conducted after regulatory approval, it combines the epidemiological rigour of matching with the breadth of post-authorization pharmacovigilance, generating evidence that randomized trials are rarely powered or timed to provide.A cohort study assembles a group of individuals who share a common starting point — typically freedom from the outcome of interest — and follows them over time to observe who develops the outcome. By comparing incidence rates between exposed and unexposed subgroups, researchers can estimate relative risk and absolute risk differences. Cohort studies are the gold-standard observational design for measuring disease incidence and establishing temporal relationships between exposure and outcome.
ScholarGateDatensatz
  1. v1
  2. 2 Quellen
  3. PUBLISHED
  1. v1
  2. 2 Quellen
  3. PUBLISHED

Zur Suche Folien herunterladen

ScholarGateMethoden vergleichen: Matched Phase IV Study · Cohort Study. Abgerufen am 2026-06-17 von https://scholargate.app/de/compare